PL373066A1 - Związki 1-(D-cyklopropyloglicynylo)-4-(piperydyn-4-ylo) piperazyny jako inhibitory czynnika Xa proteazy seryny - Google Patents

Związki 1-(D-cyklopropyloglicynylo)-4-(piperydyn-4-ylo) piperazyny jako inhibitory czynnika Xa proteazy seryny

Info

Publication number
PL373066A1
PL373066A1 PL03373066A PL37306603A PL373066A1 PL 373066 A1 PL373066 A1 PL 373066A1 PL 03373066 A PL03373066 A PL 03373066A PL 37306603 A PL37306603 A PL 37306603A PL 373066 A1 PL373066 A1 PL 373066A1
Authority
PL
Poland
Prior art keywords
inhibitors
cyclopropylglycinyl
piperidin
certain
serine protease
Prior art date
Application number
PL03373066A
Other languages
English (en)
Inventor
Michael Robert Wiley
Gary Lowell Engel
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL373066A1 publication Critical patent/PL373066A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL03373066A 2002-04-01 2003-03-24 Związki 1-(D-cyklopropyloglicynylo)-4-(piperydyn-4-ylo) piperazyny jako inhibitory czynnika Xa proteazy seryny PL373066A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01

Publications (1)

Publication Number Publication Date
PL373066A1 true PL373066A1 (pl) 2005-08-08

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373066A PL373066A1 (pl) 2002-04-01 2003-03-24 Związki 1-(D-cyklopropyloglicynylo)-4-(piperydyn-4-ylo) piperazyny jako inhibitory czynnika Xa proteazy seryny

Country Status (25)

Country Link
US (1) US7166606B2 (pl)
EP (1) EP1492767B1 (pl)
JP (1) JP2005531529A (pl)
KR (1) KR20040094892A (pl)
CN (1) CN1288135C (pl)
AT (1) ATE303990T1 (pl)
AU (1) AU2003218147A1 (pl)
BR (1) BR0308870A (pl)
CA (1) CA2478340A1 (pl)
CR (1) CR7497A (pl)
DE (1) DE60301569T2 (pl)
DK (1) DK1492767T3 (pl)
EA (1) EA007300B1 (pl)
EC (1) ECSP045329A (pl)
ES (1) ES2248737T3 (pl)
HK (1) HK1070363A1 (pl)
HR (1) HRP20040900B1 (pl)
IL (1) IL164018A0 (pl)
MX (1) MXPA04009640A (pl)
NO (1) NO20044688L (pl)
NZ (1) NZ535402A (pl)
PL (1) PL373066A1 (pl)
UA (1) UA76849C2 (pl)
WO (1) WO2003084929A1 (pl)
ZA (1) ZA200407418B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
WO2002082271A1 (en) 2001-04-05 2002-10-17 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP3541381B1 (en) * 2016-11-18 2022-12-28 Merck Sharp & Dohme LLC Inhibitors of factor xiia
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69830410T2 (de) 1997-08-29 2006-01-26 Tularik Ltd. Meta-benzamidinderivate als serinprotease-inhibitoren
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
EP1192135A2 (en) 1999-06-14 2002-04-03 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
ES2298386T3 (es) * 2001-07-26 2008-05-16 Eli Lilly And Company 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa.

Also Published As

Publication number Publication date
EA007300B1 (ru) 2006-08-25
JP2005531529A (ja) 2005-10-20
WO2003084929A1 (en) 2003-10-16
EP1492767A1 (en) 2005-01-05
US7166606B2 (en) 2007-01-23
ES2248737T3 (es) 2006-03-16
ECSP045329A (es) 2004-11-26
EP1492767B1 (en) 2005-09-07
DE60301569T2 (de) 2006-06-14
DK1492767T3 (da) 2005-11-28
IL164018A0 (en) 2005-12-18
AU2003218147A1 (en) 2003-10-20
BR0308870A (pt) 2005-01-04
UA76849C2 (uk) 2006-09-15
HK1070363A1 (en) 2005-06-17
ATE303990T1 (de) 2005-09-15
ZA200407418B (en) 2005-09-15
HRP20040900B1 (en) 2006-02-28
NZ535402A (en) 2006-02-24
HRP20040900A2 (en) 2004-12-31
DE60301569D1 (de) 2005-10-13
CA2478340A1 (en) 2003-10-16
WO2003084929A8 (en) 2004-05-21
US20050096328A1 (en) 2005-05-05
NO20044688L (no) 2004-10-29
MXPA04009640A (es) 2005-01-11
CN1288135C (zh) 2006-12-06
CN1642914A (zh) 2005-07-20
CR7497A (es) 2005-01-17
EA200401290A1 (ru) 2005-02-24
KR20040094892A (ko) 2004-11-10

Similar Documents

Publication Publication Date Title
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
IS2416B (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
MX2007005408A (es) Compuestos de aminoquinazolinas.
RS20050046A (en) 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition
UA88163C2 (ru) Cgrp-антагонисты, способ их получения, а также их применение как лекарственных средств
PL362834A1 (pl) Pochodne fenylu
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
MXPA02011411A (es) Inhibidores de proteasa de serina.
WO2004031145A3 (en) Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
GB0030303D0 (en) Compounds
GB0030306D0 (en) Compounds
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
MXPA03010205A (es) Derivados de acido oxalico.
MY137876A (en) Pharmaceutical compound
TW200603806A (en) Pharmaceutical compound
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze
MXPA04003477A (es) Sintesis de 4-(piperidil)-(2-piridil)metanona-(e)-o-metiloxima y sales.
RS20050063A (en) Pyrrolidine derivatives as tryptase inhibitors

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)